Literature DB >> 20388012

Self-efficacy mediates the relationship between depression and length of abstinence after treatment among youth but not among adults.

Danielle E Ramo1, Mark G Myers, Sandra A Brown.   

Abstract

We present two studies testing whether self-efficacy mediates the relationship between depression symptoms and initial abstinence duration after substance use treatment in adolescents and adults. Study 1: Adolescents (N = 208) were recruited from substance use treatment in an urban/suburban area in the United States between 1999 and 2005 and were followed monthly after discharge. Measures used were affective state (depression symptoms), drug-taking coping self-efficacy, and length of abstinence after treatment. Self-efficacy fully mediated the relationship between depression and time to use. Study 2: In a similar study design, adult veterans (N = 160) in outpatient substance user treatment were interviewed during treatment and monthly following treatment. Depression was negatively associated with self-efficacy, and self-efficacy predicted time to first substance use, but there was no mediation. Study implications and limitations are noted.

Entities:  

Mesh:

Year:  2010        PMID: 20388012      PMCID: PMC3031168          DOI: 10.3109/10826081003710304

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  39 in total

1.  Depression among cocaine abusers in treatment: relation to cocaine and alcohol use and treatment outcome.

Authors:  R A Brown; P M Monti; M G Myers; R A Martin; T Rivinus; M E Dubreuil; D J Rohsenow
Journal:  Am J Psychiatry       Date:  1998-02       Impact factor: 18.112

2.  Outcome and efficacy expectancy in the prediction of post-treatment drinking behaviour.

Authors:  K E Solomon; H M Annis
Journal:  Br J Addict       Date:  1990-05

3.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

4.  Depression and smoking cessation: the role of motivation and self-efficacy.

Authors:  A Haukkala; A Uutela; E Vartiainen; A McAlister; P Knekt
Journal:  Addict Behav       Date:  2000 Mar-Apr       Impact factor: 3.913

5.  Context of relapse for substance-dependent adults with and without comorbid psychiatric disorders.

Authors:  Susan R Tate; Sandra A Brown; Marina Unrod; Danielle E Ramo
Journal:  Addict Behav       Date:  2004-12       Impact factor: 3.913

6.  Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence.

Authors:  Frances R Levin; Adam Bisaga; Wilfrid Raby; Efrat Aharonovich; Eric Rubin; John Mariani; Daniel J Brooks; Fatima Garawi; Edward V Nunes
Journal:  J Subst Abuse Treat       Date:  2007-06-15

7.  Psychopathology in hospitalized alcoholics.

Authors:  M N Hesselbrock; R E Meyer; J J Keener
Journal:  Arch Gen Psychiatry       Date:  1985-11

8.  The role of psychiatric disorders in predicting drug dependence treatment outcomes.

Authors:  Wilson M Compton; Linda B Cottler; Jacqueline L Jacobs; Arbi Ben-Abdallah; Edward L Spitznagel
Journal:  Am J Psychiatry       Date:  2003-05       Impact factor: 18.112

Review 9.  Comorbidity for alcoholism and depression.

Authors:  K R Merikangas; C S Gelernter
Journal:  Psychiatr Clin North Am       Date:  1990-12

10.  Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes.

Authors: 
Journal:  Alcohol Clin Exp Res       Date:  1998-09       Impact factor: 3.455

View more
  2 in total

1.  Demographical and psychological determinants of depression, among a sample of Iranian male adolescents.

Authors:  Fazlollah Ghofranipour; Mohsen Saffari; Mahmoud Mahmoudi; Ali Montazeri
Journal:  Int J Prev Med       Date:  2013-10

2.  The Psychometric Properties of the Swedish Version of the General Self-Efficacy Scale: A Rasch Analysis Based on Adolescent Data.

Authors:  Victoria Lönnfjord; Curt Hagquist
Journal:  Curr Psychol       Date:  2017-01-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.